News Headlines

  1. ERT Expands eCOA Solution For Higher Fidelity CNS Assessments 7/22/2020

    ERT, the global leader in clinical endpoint data collection, today announced a preferred partnership with the leading neuroscience technology company, Cogstate, Ltd. The collaboration enables ERT to expand its industry-leading electronic Clinical Outcome Assessment (eCOA) solution with digital cognitive endpoint measurement to improve safety and efficacy assessment in clinical trials, including capabilities for at-home testing.

  2. Cognizant Shared Investigator Platform For Life Sciences Reaches Major Milestone In Accelerating Drug Discovery 7/21/2020

    Cognizant (Nasdaq: CTSH) announced that its Shared Investigator Platform (SIP), a life sciences Software as a Service (SaaS) solution, has reached a new milestone of over 100,000 users in 84 countries.

  3. Thermo Fisher Scientific And CSL Enter Strategic Partnership To Provide Best-In-Class Pharma Services 7/1/2020

    Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and global biotechnology company, CSL Limited (ASX:CSL;USOTC:CSLLY) today announced they have entered into a strategic partnership to help meet the growing demand for biologic therapies while also accelerating CSL's broader manufacturing objectives.

  4. CluePoints Launches Powerful Business Intelligence Platform 6/25/2020

    CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the launch of its new business intelligence platform, BEYOND. Designed to encompass more than just early risk detection, this extended visualization solution takes CluePoints beyond the interrogation of data and allows Sponsor and CRO users to explore areas of interest in one integrated business intelligence system.

  5. ERT Continues To Drive Innovation In Virtualization For Respiratory Clinical Trials 6/25/2020

    ERT, the global leader in clinical endpoints data collection, today announced a strategic partnership with Inofab Health, a healthcare technology company designing and developing ultrasonic spirometry technology for in-clinic and at-home use.

  6. CISCRP Explores The Impact Of COVID-19 On Clinical Research 5/26/2020

    The recent public healthcare crisis has generated an increasing amount of attention on the topic of clinical research. In light of this, CISCRP conducted a brief survey among the public and patients in April 2020 to assess the impact of the pandemic on clinical research perceptions and experiences.

  7. UBC's Digital Concierge Transforms Patient Access And Adherence Programs 5/26/2020

    UBC, a leader in global late-stage and patient support services for the biopharmaceutical industry, introduces UBC Pathways® Engage – a digital concierge that transforms traditional patient education, support and communications through a combination of proprietary engagement methodologies and mobile messaging technology. UBC Pathways® Engage is purpose-built to help patients start and stay on therapy.

  8. New Patient Recruitment Centres To Improve Patient Access To Commercial Clinical Research Across England 5/22/2020

    NHS patients will benefit from easier access to clinical research opportunities, following a £7M government investment to launch five new regional Patient Recruitment Centres (PRCs) across England.

  9. Parexel Launches New #KeepingPatientsFirst Integrated Research Platform Powered By Microsoft Azure Providing Rapid Access To Critical New COVID-19 Data 5/20/2020

    Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through Commercialization announced the launch of the #KeepingPatientsFirst integrated Real-World Evidence (RWE) research platform collating critical evidence and accelerating patient and physician access to insights on treatment and outcomes in COVID-19.

  10. Advarra Calls Research Sites ‘Unsung Heroes’ Of COVID-19 Crisis 5/19/2020

    Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research technology solutions, and quality and compliance consulting services, recognizes research sites as heroes of the COVID-19 crisis on Clinical Trials Day.